|
US7199231B1
(en)
|
1991-05-23 |
2007-04-03 |
Ludwig Institute For Cancer Research |
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-4 and 41 and uses thereof
|
|
GB9524973D0
(en)
|
1995-12-06 |
1996-02-07 |
Lynxvale Ltd |
Viral vectors
|
|
AU5992999A
(en)
|
1998-10-02 |
2000-04-26 |
Ludwig Institute For Cancer Research |
Tumor antigens and ctl clones isolated by a novel procedure
|
|
US7311914B2
(en)
|
2002-08-13 |
2007-12-25 |
Ludwig Institute For Cancer Research |
MAGE-A4 antigenic peptides and uses thereof
|
|
AU2003264009A1
(en)
|
2002-08-15 |
2004-03-03 |
Epitomics, Inc. |
Humanized rabbit antibodies
|
|
CN100415765C
(zh)
|
2003-08-07 |
2008-09-03 |
宜康公司 |
兔单克隆抗体的人源化方法
|
|
US7807392B1
(en)
|
2003-09-15 |
2010-10-05 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
CN101287831B
(zh)
|
2005-09-13 |
2013-05-15 |
国立大学法人三重大学 |
T细胞受体和编码该受体的核酸
|
|
NZ579594A
(en)
|
2007-03-12 |
2012-03-30 |
Esbatech Alcon Biomed Res Unit |
Sequence based engineering and optimization of single chain antibodies
|
|
NZ601583A
(en)
|
2007-05-21 |
2013-08-30 |
Bristol Myers Squibb Co |
Novel rabbit antibody humanization methods and humanized rabbit antibodies
|
|
NZ581468A
(en)
|
2007-06-25 |
2012-09-28 |
Esbatech Alcon Biomed Res Unit |
Methods of modifying antibodies, and modified antibodies with improved functional properties
|
|
CN101688200B
(zh)
|
2007-06-25 |
2012-08-08 |
艾斯巴技术,爱尔康生物医药研究装置有限责任公司 |
单链抗体的基于序列的改造和优化
|
|
PL2307455T3
(pl)
|
2008-06-25 |
2017-09-29 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Optymalizacja rozpuszczalności cząsteczek immunowiążących
|
|
PL2307458T3
(pl)
|
2008-06-25 |
2018-08-31 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Humanizacja przeciwciał króliczych z zastosowaniem uniwersalnego zrębu przeciwciała
|
|
CA2771575A1
(en)
*
|
2009-08-29 |
2011-03-03 |
Abbott Laboratories |
Therapeutic dll4 binding proteins
|
|
WO2013048243A1
(en)
|
2011-09-29 |
2013-04-04 |
Apo-T B.V. |
Multi-specific binding molecules targeting aberrant cells
|
|
HK1245171A1
(zh)
|
2014-11-26 |
2018-08-24 |
Xencor, Inc. |
结合cd3和cd38的异二聚体抗体
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
|
MX395611B
(es)
*
|
2016-04-08 |
2025-03-25 |
Adaptimmune Ltd |
Receptores de celulas t.
|
|
KR20190065189A
(ko)
|
2016-04-08 |
2019-06-11 |
어댑티뮨 리미티드 |
T 세포 수용체
|
|
IL308831A
(en)
|
2016-04-08 |
2024-01-01 |
Immunocore Ltd |
T cell receptors
|
|
HRP20251020T1
(hr)
|
2016-05-20 |
2025-10-24 |
Harpoon Therapeutics, Inc. |
Proteini s jednolančanim varijabilnim fragmentom koji vežu cd3
|
|
US11590098B2
(en)
*
|
2016-09-06 |
2023-02-28 |
Mayo Foundation For Medical Education And Research |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
EP3601536A4
(en)
|
2017-03-20 |
2021-01-13 |
Genocea Biosciences, Inc. |
TREATMENT PROCEDURES
|
|
ES2991091T3
(es)
*
|
2017-06-05 |
2024-12-02 |
Univ Mie |
Proteína de unión a antígeno que reconoce el péptido derivado de MAGE-A4
|
|
MX2020001879A
(es)
|
2017-08-18 |
2020-07-29 |
Gritstone Oncology Inc |
Proteínas de fijación al antígeno que se dirigen a antígenos compartidos.
|
|
AU2018395397A1
(en)
|
2017-12-28 |
2020-08-06 |
Gritstone Bio, Inc. |
Antigen-binding proteins targeting shared antigens
|
|
GB201803750D0
(en)
|
2018-03-08 |
2018-04-25 |
Immunocore Ltd |
Method
|
|
JP7326764B2
(ja)
|
2018-03-09 |
2023-08-16 |
東ソー株式会社 |
腫瘍マーカーならびに腫瘍細胞を夾雑細胞と区別して回収および検出する方法
|
|
CA3102254A1
(en)
|
2018-06-04 |
2019-12-12 |
Apo-T B.V. |
Methods and means for attracting immune effector cells to tumor cells
|
|
CN108866098A
(zh)
|
2018-07-27 |
2018-11-23 |
北京安斯晨睿生物科技有限公司 |
携带mage-a4突变抗原基因的重组腺相关病毒载体及其构建方法与应用
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
GB201901306D0
(en)
|
2019-01-30 |
2019-03-20 |
Immunocore Ltd |
Multi-domain binding molecules
|
|
EP3714941A1
(en)
*
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
MX2021015946A
(es)
|
2019-06-18 |
2022-04-18 |
Regeneron Pharma |
Receptores de linfocitos t de mage-a4 y métodos de uso de estos.
|
|
BR112022001194A2
(pt)
*
|
2019-07-24 |
2022-06-07 |
Regeneron Pharma |
Receptores de antígeno quimérico com especificidade de mage a4 e usos dos mesmos
|
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
CN110333352A
(zh)
|
2019-08-07 |
2019-10-15 |
基因科技(上海)股份有限公司 |
肿瘤相关自身抗体及肿瘤标志物联合检测试剂盒
|
|
CN114828965B
(zh)
*
|
2019-12-18 |
2025-09-05 |
豪夫迈·罗氏有限公司 |
与hla-a2/mage-a4结合的抗体
|
|
CN115803340A
(zh)
|
2020-04-24 |
2023-03-14 |
纪念斯隆凯特琳癌症中心 |
抗cd3抗体及其用途
|
|
CN116096754A
(zh)
|
2020-05-04 |
2023-05-09 |
免疫里森公司 |
前体三特异性抗体构建体及其使用方法
|
|
EP4149631A1
(en)
|
2020-05-13 |
2023-03-22 |
Adaptimmune Limited |
Method of treatment of cancer or tumour
|
|
US20230190803A1
(en)
|
2020-05-13 |
2023-06-22 |
Adaptimmune Limited |
Method of treatment of cancer or tumour
|
|
CN118878693A
(zh)
|
2020-11-23 |
2024-11-01 |
康诺亚生物医药科技(成都)有限公司 |
一种双特异性抗体及其用途
|
|
US12435444B2
(en)
|
2021-03-09 |
2025-10-07 |
Cdr-Life Ag |
Rabbit-derived antigen binding protein nucleic acid libraries and methods of making the same
|
|
EP4304726A1
(en)
|
2021-03-09 |
2024-01-17 |
CDR-Life AG |
Mage-a4 peptide-mhc antigen binding proteins
|
|
JP2024516308A
(ja)
|
2021-05-04 |
2024-04-12 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Mage-a4特異性を有するキメラ抗原受容体及びその使用
|
|
WO2022262678A1
(zh)
|
2021-06-15 |
2022-12-22 |
盛禾(中国)生物制药有限公司 |
一种多特异性抗原结合蛋白及其应用
|
|
US20240327543A1
(en)
|
2021-08-02 |
2024-10-03 |
Shenghe (China) Biopharmaceutical Co., Ltd. |
Multispecific antigen-binding protein and use thereof
|
|
CN117730103A
(zh)
|
2021-08-02 |
2024-03-19 |
盛禾(中国)生物制药有限公司 |
一种多特异性抗原结合蛋白及其应用
|
|
KR20240040097A
(ko)
|
2021-08-04 |
2024-03-27 |
에이비프로 코퍼레이션 |
Cd3 표적화 항체 및 이의 용도
|
|
CA3231006A1
(en)
|
2021-09-17 |
2023-03-23 |
Adimab, Llc |
Anti-cd3 antibodies
|